Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Sep 11, 2024 (2 years ago)

First Aid Antiseptic Ointment (Povidone-Iodine)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

First Aid Antiseptic Ointment, Povidone Iodine USP 10%, Inactive Ingredients: mineral oil, petrolatum. NET Wt. 1 OZ (28.4 g) per tube, Distributed by: Rugby Laboratories, Indianapolis, IN 46268. Made in China. NDC: 0536-1271-80

Affected NDC 0536-1271-80

Compare with the code on your package — it is the most precise check available.

Drug: Iodine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
First Aid Antiseptic
Povidone-Iodine
NDC 00536-1271
100 mg/g Ointment
Topical
Rugby Laboratories OTC
Recalling firm
Zhejiang Jingwei Pharmaceutical Co., Ltd.
Origin
China
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0013-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Iodine recalls

See all
Class II · Moderate risk

BD PurPrep

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0644-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-41 D-0518-2026

Other chemical / undeclared recalls from 2024

All chemical / undeclared recalls
Class II · Moderate risk

Umary Acid Hyaluronic

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Ongoing Chemical / undeclared Mxbbb D-0166-2025